Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Israel
100%
COVID-19
79%
BNT162b2
42%
BNT162b2 Vaccine
38%
Infection Rate
30%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
27%
Vaccine Effectiveness
25%
Severe Disease
25%
Vaccination
24%
Age Groups
19%
95% Confidence Interval
19%
Booster Dose
18%
Phytoplankton Bloom
17%
Vaccinated Individuals
17%
Second Dose
17%
Israeli
16%
Fully Vaccinated
15%
Coral
15%
Polio
14%
Infectivity
14%
Viral Load
14%
SARS-CoV-2 Variants
12%
Retrospective Cohort Study
12%
Infectious Diseases
12%
Previous Infection
12%
Hospitalization
12%
Threshold Effect
11%
El Niño
11%
Sea Surface Temperature
11%
SARS-CoV-2 Omicron
11%
Hybrid Immunity
11%
Unvaccinated
11%
Oral Polio Vaccine
10%
Incidence Data
10%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
10%
Vaccine Dose
9%
Reproductive number
9%
Vaccine Campaign
9%
Vector-borne Diseases
9%
Age-dependent
9%
Waning Immunity
9%
Parameter Estimation
9%
Disease Spread
9%
Population Level
8%
Internal Control
8%
Environmental Monitoring
8%
Omicron Variant
8%
Booster Campaigns
8%
Viral Genome
7%
PCR Test
7%
Immunology and Microbiology
Infection
88%
Infectious Disease
83%
COVID-19
56%
Severe Acute Respiratory Syndrome Coronavirus 2
55%
Prey
27%
Omicron Coronavirus Variant
24%
Streptococcus pneumonia
23%
Susceptibility
17%
Predation
17%
Prevalence
16%
Influenza
14%
Booster Dose
14%
Viral Load
12%
Plankton
11%
Upper Respiratory Tract
11%
Serotype
11%
Hybrid Immunity
11%
COVID-19 Vaccination
11%
Bdellovibrio
11%
Adolescence
11%
Pneumococcal Vaccine
10%
Infection Rate
9%
Receptor Binding
7%
Antimicrobial Agent
7%
Antibody Response
7%
Comorbidity
7%
Antibiotic Resistance
7%
Infectious Agent
7%
Antigen
7%
Neutralizing Antibody
6%
Bacterium
6%
Lineages
5%
Polymerase Chain Reaction
5%
Humoral Immunity
5%
CD4 Lymphocyte Count
5%
Antigenic Drift
5%
Dilution
5%
Immunogenicity
5%
Age Distribution
5%
Innate Immunity
5%
Staphylococcus Aureus
5%
Poliomyelitis Virus
5%
Enzyme Immunoassay
5%
Haemophilus influenzae
5%
Parasite
5%
Human Immunodeficiency Virus 1
5%
Immunocompromised Patient
5%
Influenza A Virus (H1N1)
5%
Nontypeable Haemophilus Influenzae
5%
Parasitemia
5%